These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686 [TBL] [Abstract][Full Text] [Related]
5. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1. Wang L; Liu H Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981 [TBL] [Abstract][Full Text] [Related]
6. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5. Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Sarver AL; Li L; Subramanian S Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966 [TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328. Paduano F; Dattilo V; Narciso D; Bilotta A; Gaudio E; Menniti M; Agosti V; Palmieri C; Perrotti N; Fusco A; Trapasso F; Iuliano R FEBS J; 2013 Jan; 280(2):401-12. PubMed ID: 22564856 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma. Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases. Takayama S; Hatori M; Kurihara Y; Kinugasa Y; Shirota T; Shintani S Oncol Rep; 2009 Jan; 21(1):205-10. PubMed ID: 19082463 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785 [TBL] [Abstract][Full Text] [Related]
13. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Chang KW; Kao SY; Wu YH; Tsai MM; Tu HF; Liu CJ; Lui MT; Lin SC Oral Oncol; 2013 Jan; 49(1):27-33. PubMed ID: 22854067 [TBL] [Abstract][Full Text] [Related]
14. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270 [TBL] [Abstract][Full Text] [Related]
15. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Xu X; Chen Z; Zhao X; Wang J; Ding D; Wang Z; Tan F; Tan X; Zhou F; Sun J; Sun N; Gao Y; Shao K; Li N; Qiu B; He J Biochem Biophys Res Commun; 2012 May; 421(4):640-5. PubMed ID: 22450326 [TBL] [Abstract][Full Text] [Related]
17. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9. Rastogi B; Kumar A; Raut SK; Panda NK; Rattan V; Joshi N; Khullar M Cancer Invest; 2017 Mar; 35(3):152-162. PubMed ID: 28267394 [TBL] [Abstract][Full Text] [Related]
19. MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1. Liu C; Wang Z; Wang Y; Gu W Mol Cell Biochem; 2015 Jan; 398(1-2):115-22. PubMed ID: 25204970 [TBL] [Abstract][Full Text] [Related]
20. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. Yang CJ; Shen WG; Liu CJ; Chen YW; Lu HH; Tsai MM; Lin SC J Oral Pathol Med; 2011 Aug; 40(7):560-6. PubMed ID: 21226887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]